162 related articles for article (PubMed ID: 24135282)
1. DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signaling.
Steder M; Alla V; Meier C; Spitschak A; Pahnke J; Fürst K; Kowtharapu BS; Engelmann D; Petigk J; Egberts F; Schäd-Trcka SG; Gross G; Nettelbeck DM; Niemetz A; Pützer BM
Cancer Cell; 2013 Oct; 24(4):512-27. PubMed ID: 24135282
[TBL] [Abstract][Full Text] [Related]
2. DNp73: oncotarget in invasion and metastasis.
Pützer BM
Oncotarget; 2014 Jan; 5(1):3-4. PubMed ID: 24398448
[No Abstract] [Full Text] [Related]
3. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.
Alla V; Kowtharapu BS; Engelmann D; Emmrich S; Schmitz U; Steder M; Pützer BM
Cell Cycle; 2012 Aug; 11(16):3067-78. PubMed ID: 22871739
[TBL] [Abstract][Full Text] [Related]
4. p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem-like Features via miR-885-5p Control.
Meier C; Hardtstock P; Joost S; Alla V; Pützer BM
Cancer Res; 2016 Jan; 76(2):197-205. PubMed ID: 26554827
[TBL] [Abstract][Full Text] [Related]
5. DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression.
Fürst K; Steder M; Logotheti S; Angerilli A; Spitschak A; Marquardt S; Schumacher T; Engelmann D; Herchenröder O; Rupp RAW; Pützer BM
Cancer Lett; 2019 Feb; 442():299-309. PubMed ID: 30445206
[TBL] [Abstract][Full Text] [Related]
6. Suppression of acetylpolyamine oxidase by selected AP-1 members regulates DNp73 abundance: mechanistic insights for overcoming DNp73-mediated resistance to chemotherapeutic drugs.
Bunjobpol W; Dulloo I; Igarashi K; Concin N; Matsuo K; Sabapathy K
Cell Death Differ; 2014 Aug; 21(8):1240-9. PubMed ID: 24722210
[TBL] [Abstract][Full Text] [Related]
7. p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis.
Johnson J; Lagowski J; Lawson S; Liu Y; Kulesz-Martin M
Oncogene; 2008 Apr; 27(19):2780-7. PubMed ID: 18026135
[TBL] [Abstract][Full Text] [Related]
8. Expression of p16, p27, p53, p73 and Nup88 proteins in matched primary and metastatic melanoma cells.
Zhang H; Schneider J; Rosdahl I
Int J Oncol; 2002 Jul; 21(1):43-8. PubMed ID: 12063548
[TBL] [Abstract][Full Text] [Related]
9. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
Li L; Zhang S; Li H; Chou H
BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
[TBL] [Abstract][Full Text] [Related]
10. DNp73 a matter of cancer: mechanisms and clinical implications.
Buhlmann S; Pützer BM
Biochim Biophys Acta; 2008 Apr; 1785(2):207-16. PubMed ID: 18302944
[TBL] [Abstract][Full Text] [Related]
11. The antiapoptotic DeltaNp73 is degraded in a c-Jun-dependent manner upon genotoxic stress through the antizyme-mediated pathway.
Dulloo I; Gopalan G; Melino G; Sabapathy K
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):4902-7. PubMed ID: 20185758
[TBL] [Abstract][Full Text] [Related]
12. The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells.
Nahor I; Abramovitch S; Engeland K; Werner H
Growth Horm IGF Res; 2005 Dec; 15(6):388-96. PubMed ID: 16181796
[TBL] [Abstract][Full Text] [Related]
13. DNp73 improves generation efficiency of human induced pluripotent stem cells.
Lin Y; Cheng Z; Yang Z; Zheng J; Lin T
BMC Cell Biol; 2012 Mar; 13():9. PubMed ID: 22449255
[TBL] [Abstract][Full Text] [Related]
14. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
Vera J; Schmitz U; Lai X; Engelmann D; Khan FM; Wolkenhauer O; Pützer BM
Cancer Res; 2013 Jun; 73(12):3511-24. PubMed ID: 23447575
[TBL] [Abstract][Full Text] [Related]
15. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
[TBL] [Abstract][Full Text] [Related]
16. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.
Wang J; Hua W; Huang SK; Fan K; Takeshima L; Mao Y; Hoon DS
Oncotarget; 2015 Oct; 6(30):30165-77. PubMed ID: 26334503
[TBL] [Abstract][Full Text] [Related]
17. A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.
Engelmann D; Meier C; Alla V; Pützer BM
Oncogene; 2015 Aug; 34(33):4287-99. PubMed ID: 25381823
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms, function and clinical applications of DNp73.
Di C; Yang L; Zhang H; Ma X; Zhang X; Sun C; Li H; Xu S; An L; Li X; Bai Z
Cell Cycle; 2013 Jun; 12(12):1861-7. PubMed ID: 23708520
[TBL] [Abstract][Full Text] [Related]
19. A novel role for p73 in the regulation of Akt-Foxo1a-Bim signaling and apoptosis induced by the plant lectin, Concanavalin A.
Amin AR; Paul RK; Thakur VS; Agarwal ML
Cancer Res; 2007 Jun; 67(12):5617-21. PubMed ID: 17575126
[TBL] [Abstract][Full Text] [Related]
20. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
